Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.84%16.63B | 11.91%4.4B | -2.55%3.98B | 2.26%4.3B | 0.03%3.96B | 0.21%16.17B | 0.10%3.93B | -2.64%4.08B | 1.84%4.21B | 1.67%3.96B |
Cost of revenue | 2.76%12.63B | 13.04%3.36B | -2.48%3.01B | 1.70%3.28B | -0.88%2.98B | -0.88%12.29B | -2.63%2.97B | -3.30%3.09B | 2.99%3.22B | -0.56%3.01B |
Gross profit | 3.12%4B | 8.41%1.04B | -2.76%961.43M | 4.08%1.03B | 2.91%976.28M | 3.84%3.88B | 9.65%957.21M | -0.51%988.66M | -1.75%987.77M | 9.48%948.72M |
Operating expense | 4.52%3.76B | 5.01%967.91M | 1.61%928.95M | 5.92%934.86M | 5.62%925.13M | 4.22%3.59B | 5.16%921.7M | 5.75%914.25M | 2.87%882.65M | 3.06%875.89M |
Staff costs | 1.63%1.71B | ---- | ---- | ---- | ---- | 3.60%1.69B | ---- | ---- | ---- | ---- |
Depreciation and amortization | 13.37%284.48M | ---- | ---- | ---- | ---- | 21.43%250.92M | ---- | ---- | ---- | ---- |
-Depreciation | 13.37%284.48M | ---- | ---- | ---- | ---- | 21.43%250.92M | ---- | ---- | ---- | ---- |
Rent and land expenses | 1.10%433.48M | ---- | ---- | ---- | ---- | 0.40%428.76M | ---- | ---- | ---- | ---- |
Other operating expenses | 7.87%1.33B | ---- | ---- | ---- | ---- | 3.45%1.23B | ---- | ---- | ---- | ---- |
Operating profit | -14.31%246.68M | 96.70%69.84M | -56.36%32.48M | -11.34%93.21M | -29.77%51.15M | -0.65%287.88M | 1,097.89%35.51M | -42.42%74.42M | -28.67%105.13M | 336.79%72.83M |
Net non-operating interest income (expenses) | -14.52%-64.25M | -13.18%-16.17M | -22.35%-16.09M | -5.01%-16.15M | -19.25%-15.84M | 5.02%-56.11M | -1.00%-14.29M | 8.31%-13.15M | -1.08%-15.38M | 13.55%-13.28M |
Non-operating interest income | -94.54%120K | -69.53%117K | ---- | ---- | --0 | -31.21%2.2M | -56.21%384K | ---- | ---- | 47.37%868K |
Non-operating interest expense | 10.41%64.37M | 11.01%16.29M | 7.55%16.09M | 11.29%16.15M | 11.93%15.84M | -6.37%58.3M | -2.34%14.68M | -1.52%14.96M | -9.81%14.51M | -11.30%14.15M |
Net investment income | 10.83%1.99M | 50K | 11.52%997K | 0 | 4.57%938K | 11.87%1.79M | 0 | 13.02%894K | 0 | 10.74%897K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 102.53%702K | 128.91%7.62M | 138.21%1.08M | -418.71%-4.46M | -3.54M | -26.86%-27.78M | 27.99%-26.35M | -136.18%-2.83M | -79.61%1.4M | 0 |
Less:Restructuring and mergern&acquisition | ---18.65M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Less:Other special charges | -88.35%2.76M | -115.77%-4.16M | 14.45%-1.08M | --4.46M | --3.54M | 360.96%23.68M | 369.41%26.35M | 83.84%-1.27M | ---- | ---- |
Less:Write off | 270.34%15.18M | --15.18M | ---- | ---- | ---- | -86.76%4.1M | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 42.78%67.61M | 210.33%20.16M | 20.41%20.87M | -15.78%9.4M | 38.99%17.17M | 124.49%47.35M | 57.66%6.5M | 56.82%17.33M | 348.33%11.17M | 18.63%12.35M |
Income before tax | -0.17%252.71M | 5,900.88%81.49M | -48.69%39.34M | -19.85%82M | -31.48%49.88M | 9.36%253.13M | 102.71%1.36M | -43.04%76.66M | -23.95%102.31M | 481.36%72.8M |
Income tax | 29.83%-8.62M | -12.41%-29.44M | -18.00%24.11M | -50.40%-16.56M | 395.81%13.27M | -134.51%-12.28M | -4.33%-26.19M | -4.15%29.4M | -248.80%-11.01M | -119.83%-4.49M |
Net income | -1.54%261.33M | 302.65%110.94M | -67.78%15.23M | -13.03%98.56M | -52.63%36.61M | 35.50%265.42M | 209.89%27.55M | -54.52%47.26M | -10.87%113.32M | 865.42%77.28M |
Net income continuous operations | -1.54%261.33M | 302.68%110.93M | -67.78%15.23M | -13.03%98.56M | -52.63%36.61M | 35.50%265.42M | 209.88%27.55M | -54.52%47.26M | -10.87%113.32M | 865.42%77.28M |
Noncontrolling interests | 0 | 0 | 0 | 0 | ||||||
Net income attributable to the company | -1.54%261.33M | 302.65%110.94M | -67.78%15.23M | -13.03%98.56M | -52.63%36.61M | 35.50%265.42M | 209.89%27.55M | -54.52%47.26M | -10.87%113.32M | 865.42%77.28M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -1.54%261.33M | 302.65%110.94M | -67.78%15.23M | -13.03%98.56M | -52.63%36.61M | 35.50%265.42M | 209.89%27.55M | -54.52%47.26M | -10.87%113.32M | 865.42%77.28M |
Gross dividend payment | ||||||||||
Basic earnings per share | -3.28%81.01 | 317.86%34.39 | -67.71%4.74 | -15.59%30.54 | -54.03%11.34 | 33.95%83.76 | 202.88%8.23 | -55.74%14.68 | -10.84%36.18 | 866.15%24.67 |
Diluted earnings per share | -3.28%81.01 | 317.86%34.39 | -67.84%4.7215 | -15.58%30.54 | -54.03%11.34 | 33.95%83.76 | 202.83%8.23 | -55.74%14.68 | -10.85%36.1765 | 866.15%24.67 |
Dividend per share | 11.76%19 | 11.76%19 | 0 | 0 | 0 | 13.33%17 | 13.33%17 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |